How immune cells in the retina respond when light-sensing cells are dying
Cellular and Molecular Dynamics of Retinal Microglial in the Context of Photoreceptor Degeneration
This work looks at how retinal immune cells clear dying photoreceptors to help people with age-related macular degeneration and inherited retinal degenerations.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11192288 on NIH RePORTER |
What this research studies
From your perspective, researchers are following immune cells called microglia to see how they remove dead photoreceptor debris and protect remaining retinal cells. They use animal models of photoreceptor degeneration and single-cell RNA sequencing to map microglia behavior and gene activity. The team also examines human donor (postmortem) AMD eyes for matching molecular markers and tissue patterns. Their goal is to identify the cellular signals that could be targeted to slow or prevent vision loss.
Who could benefit from this research
Good fit: People with age-related macular degeneration or inherited photoreceptor degenerations, and those willing to consider tissue donation for research, are the most relevant groups.
Not a fit: People without retinal degeneration or those seeking an immediate treatment are unlikely to see direct benefit from this research now.
Why it matters
Potential benefit: If successful, this work could point to new ways to prevent secondary damage in retinal diseases and slow vision loss.
How similar studies have performed: Previous animal and human tissue studies have suggested microglia can protect photoreceptors, but translating these findings into treatments is still early and largely unproven.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Saban, Daniel Raphael — Duke University
- Study coordinator: Saban, Daniel Raphael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.